EP1648516 - USE OF COMBINATION OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR AND CYTOTOXIC AGENTS FOR TREATMENT AND INHIBITION OF CANCER [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 30.05.2008 Database last updated on 24.08.2024 | Most recent event Tooltip | 30.05.2008 | Application deemed to be withdrawn | published on 02.07.2008 [2008/27] | Applicant(s) | For all designated states Wyeth Holdings Corporation Five Giralda Farms Madison, NJ 07940 / US | [2006/17] | Inventor(s) | 01 /
GREENBERGER, Lee, Martin 253 Midland Avenue Montclair, NJ 07042 / US | 02 /
DISCAFANI-MARRO, Carolyn, Mary 8 Brookside Avenue Cortlandt Manor, NY 10567 / US | 03 /
FROST, Philip 4 Emerson Court Morris Township, NJ 07960 / US | [2006/17] | Representative(s) | Wileman, David Francis, et al Wyeth Pharmaceuticals, Huntercombe Lane South, Taplow Maidenhead Berkshire SL6 OPH / GB | [2006/17] | Application number, filing date | 04801904.6 | 28.07.2004 | [2006/17] | WO2004US24478 | Priority number, date | US20030492132P | 01.08.2003 Original published format: US 492132 P | [2006/17] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2005018677 | Date: | 03.03.2005 | Language: | EN | [2005/09] | Type: | A2 Application without search report | No.: | EP1648516 | Date: | 26.04.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.03.2005 takes the place of the publication of the European patent application. | [2006/17] | Search report(s) | International search report - published on: | EP | 26.05.2006 | Classification | IPC: | A61K45/06, A61K31/47, A61P35/00 | [2006/17] | CPC: |
A61K31/47 (EP,KR,US);
A61K45/06 (EP,KR,US);
A61P35/00 (EP);
A61P43/00 (EP)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/17] | Extension states | AL | 19.01.2006 | HR | 19.01.2006 | LT | 19.01.2006 | LV | 19.01.2006 | MK | 19.01.2006 | Title | German: | VERWENDUNG EINER KOMBINATION AUS EINEM EPIDERMALEN WACHSTUMSFAKTOR-REZEPTOR-KINASE-HEMMER UND ZYTOTOXISCHEN MITTELN ZUR BEHANDLUNG UND HEMMUNG VON KREBS | [2006/17] | English: | USE OF COMBINATION OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR AND CYTOTOXIC AGENTS FOR TREATMENT AND INHIBITION OF CANCER | [2006/17] | French: | UTILISATION D'UN MELANGE D'UN INHIBITEUR DE LA KINASE DU RECEPTEUR DE FACTEUR DE CROISSANCE EPIDERMIQUE ET D'AGENTS CYTOTOXIQUES DANS LE TRAITEMENT ET L'INHIBITION DE CANCER | [2006/17] | Entry into regional phase | 19.01.2006 | National basic fee paid | 19.01.2006 | Designation fee(s) paid | 19.01.2006 | Examination fee paid | Examination procedure | 19.01.2006 | Amendment by applicant (claims and/or description) | 19.01.2006 | Examination requested [2006/17] | 31.07.2007 | Despatch of a communication from the examining division (Time limit: M04) | 11.12.2007 | Application deemed to be withdrawn, date of legal effect [2008/27] | 18.01.2008 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2008/27] | Fees paid | Renewal fee | 10.07.2006 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.07.2007 | 04   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XD]US6384051 (FROST PHILIP [US], et al) [XD] 1-5,10,11* column 17, paragraph 3 *; | [X]WO03020266 (WYETH CORP [US]) [X] 1-6,10,11 * page 8, paragraph 2 - page 9, paragraph 1 *; | [X]WO03050090 (WYETH CORP [US]) [X] 1-5,10,11 * page 34, paragraph 2 * * page 36, paragraph 2 * |